Buscar
01/04/2022
"Skills for pills": The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder
Soler, J, Casellas-Pujol, E, Fernandez-Felipe, I, Martin-Blanco, A, Almenta, D, Pascual, JC. "Skills for pills": The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder. ACTA PSYCHIATRICA SCANDINAVICA. 2022; 145(4)DOI:10.1111/acps.13403. PMID:35088405. IF:6.700(Q1/2D).
01/04/2022
Borderline personality traits mediate the relationship between low perceived social support and non-suicidal self-injury in a clinical sample of adolescents
Mendez, I, Sintes, A, Pascual, JC, Punti, J, Lara, A, Briones-Buixassa, L, Nicolaou, S, Schmidt, C, Romero, S, Fernandez, M, Farres, CCI, Soler, J, Santamarina-Perez, P, Vega, D. Borderline personality traits mediate the relationship between low perceived social support and non-suicidal self-injury in a clinical sample of adolescents. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302DOI:10.1016/j.jad.2022.01.065. PMID:35038480. IF:6.600(Q1/2D).
01/04/2022
Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses dependent on the use of cannabis?
Amoretti, S, Verdolini, N, Varo, C, Mezquida, G, Sanchez-Torres, AM, Vieta, E, Garcia-Rizo, C, Lobo, A, Gonzalez-Pinto, A, Abregu-Crespo, R, Corripio, I, Serra, M, de la Serna, E, Mane, A, Ramos-Quiroga, JA, Ribases, M, Cuesta, MJ, Bernardo, M. Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses dependent on the use of cannabis?. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302DOI:10.1016/j.jad.2022.01.077. PMID:35066012. IF:6.600(Q1/2D).
01/04/2022
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
Martínez-Pinteño A., Mezquida G., Bioque M., López-Ilundain J.M., Andreu-Bernabeu Á., Zorrilla I., Mané A., Rodríguez-Jiménez R., Corripio I., Sarró S., Ibáñez Á., Usall J., Rivero O., Gassó P., Leza J.C., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Mas S., Bernardo M., Amoretti S., Morén C., Urbiola E., González-Peñas J., Roldán A., Catalán A., González-Ortega I., Toll A., Legido T., Sanchez-Pastor L., Dompablo M., Pomarol-Clotet E., R L.-R., Butjosa A., Rubio E., Lorente-OmeñacaR, Ribeiro M., López-Torres I., León-Quismondo L., Nácher J., Contretas F., Lobo A., Gutiérrez-Fraile M., Sáiz P.A.. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 57DOI:10.1016/j.euroneuro.2022.02.003. PMID:35219096. IF:5.600(Q1/2D).